The archive · Health & Care · Financial decision · 2020-2024
Remedial Health's pharmacy bet: vetted medicines plus inventory credit across Nigeria
YC-backed Nigerian startup digitizes pharmacy procurement with embedded inventory financing; $12M round, 7,500 customers, all 36 states.
Remedial Health
What the business is
B2B platform where Nigerian pharmacies, hospitals and proprietary patent medicine vendors order vetted medicines from manufacturers, manage inventory and sales, and restock on credit without paying upfront.
Starting capital：Pre-seed and seed rounds before Y Combinator (2022), then a $12M Series A split between equity and debt, co-led by QED Investors and Ventures Platform with Y Combinator, Tencent and Gaingels participating (2023).
How it started
Pharmacist Samuel Okwuada and Victor Benjamin started Remedial Health to fix the pharmaceutical value chain after seeing neighborhood pharmacies and medicine vendors buy from chaotic open-air drug markets with erratic prices and counterfeit stock; the company went through Y Combinator in 2022 and began selling inventory on credit.
What happened
The startup built an ordering platform with 24-hour delivery from regional hubs, an app for inventory, accounting and sales, and embedded inventory financing that lets pharmacies restock without cash at delivery. By July 2023 it served 5,000+ pharmacies and hospitals with 8,000+ products sourced from about 300 manufacturers including GSK, Pfizer and AstraZeneca, and said inventory credit drove 7x revenue growth in ten months. In 2023 it sold more than 300 million individual packs to 7,500 customers across all 36 states, and in April 2024 it launched an updated operating-system app with a digital POS terminal, virtual business accounts, barcode scanning and multi-store management.
How it ended up
Scaling: after the $12M round Remedial Health pushed from 34 states toward full national coverage, reached 7,500 hospitals, pharmacies and vendors in 2023, and in April 2024 shipped an all-in-one app that turns a pharmacy into a managed sales-and-inventory business; no exit or shutdown as of the sources' dates.
Background
Remedial Health is a Nigerian startup digitizing the pharmaceutical supply chain. Pharmacies, hospitals and proprietary patent medicine vendors (PPMVs) use its platform to order genuine medicines from manufacturers and verified distributors instead of open-air drug markets, and to run sales, inventory and accounting in one app. The company went through Y Combinator in 2022 and is backed by QED Investors, Ventures Platform, Tencent and others.
Its core innovation is inventory financing: customers restock without paying cash upfront, and Remedial Health collects later from businesses whose cash flow it can see in transaction data. TechCrunch reported in July 2023 that the model drove client count up 3x since November 2022 and revenue up 7x in ten months, to more than 5,000 pharmacies and hospitals served with over 8,000 vetted products sourced from roughly 300 manufacturers, including GSK, Pfizer and AstraZeneca.
The safety argument is part of the wedge: Nigeria's drugs regulator NAFDAC estimates about 15% of medicines sold in the country are fake or substandard, and pharmacies that buy from a vetted supply chain can point to provenance. Remedial Health says it sells only manufacturer- and distributor-sourced stock, stored and handled properly, with delivery within 24 hours from regional hubs.
By 2023 the company reported selling more than 300 million individual medicine packs to 7,500 hospitals, pharmacies and PPMVs across all 36 states, with customers' profits up 30% on average. In April 2024 it launched an updated app - a digital POS terminal, virtual business accounts, barcode scanning, multi-store switching and inventory management - positioning itself as an operating system for Africa's neighborhood pharmacies rather than just a wholesaler.
What has to be true
- Counterfeit medicines and erratic prices are concrete, life-threatening problems that give pharmacies a strong reason to switch suppliers.
- Pharmacies run on cash flow, so inventory credit without upfront payment is the feature that makes the platform indispensable.
- Transaction data from ordering gives Remedial Health better visibility into a borrower's business than any bank has, enabling credit at scale.
- Starting with neighborhood pharmacies and PPMVs - the frontline of Nigerian healthcare - created a wedge big incumbents ignore.
What can be applied
In fragmented B2B markets the product is not the catalogue, it is the financing: letting trusted buyers restock without upfront cash is what turned a pharmacy ordering app into a 7x-growth business.
Aftermath
As of April 2024 Remedial Health is scaling as a B2B e-commerce and fintech company. After the $12M Series A in 2023 it reported 7,500 hospital, pharmacy and PPMV customers across all 36 states, 300M+ medicine packs sold that year, and 3x customer growth from late 2022 to mid-2023. The April 2024 app relaunch added a digital POS, virtual business accounts, barcode scanning, multi-store management and financial reporting, extending it from procurement into payments and store operations. CEO Samuel Okwuada said the goal is continued rural expansion; sources show no exit or shutdown.
Sources
- Nigeria's Remedial Health gets QED backing in $12M round
- Nigeria's Remedial Health unveils new app to power operations for neighbourhood pharmacies
- Remedial Health unveils new app to aid Africa's healthcare operations
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card